NewAmsterdam Pharma Ownership | Who Owns NewAmsterdam Pharma?


OverviewForecastRevenueFinancialsChart

NewAmsterdam Pharma Ownership Summary


NewAmsterdam Pharma is owned by 95.75% institutional investors, 0.34% insiders, and 3.92% retail investors. Fcpm iii services b.v. is the largest institutional shareholder, holding 11.18% of NAMS shares. American Funds SMALLCAP World A is the top mutual fund, with 6.05% of its assets in NewAmsterdam Pharma shares.

NAMS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNewAmsterdam Pharma95.75%0.34%3.92%
SectorHealthcare Stocks 279.19%10.58%-189.76%
IndustryBiotech Stocks 63.97%10.68%25.35%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fcpm iii services b.v.10.60M11.18%$272.35M
Jennison associates4.00M4.22%$102.76M
Medicxi ventures management (jersey)2.87M3.03%$73.75M
Polar capital1.75M1.85%$44.98M
Timessquare capital management895.57K0.95%$23.02M
Blackrock funding, inc. /de441.52K0.47%$11.35M
Handelsbanken fonder ab187.40K0.20%$4.82M
Abrdn179.06K0.19%$4.60M
Healthinvest partners ab138.98K0.15%$3.56M
State street60.26K0.06%$1.55M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fcpm iii services b.v.10.60M45.98%$272.35M
Medicxi ventures management (jersey)2.87M13.94%$73.75M
Healthinvest partners ab138.98K1.69%$3.56M
Timessquare capital management895.57K0.34%$23.02M
Polar capital1.75M0.25%$44.98M
Lisanti capital growth38.72K0.24%$994.98K
Gsa capital partners llp54.23K0.10%$1.39M
Jennison associates4.00M0.06%$102.76M
China universal asset management19.59K0.05%$503.44K
Yarbrough capital23.96K0.02%$615.77K

Top Buyers

HolderShares% AssetsChange
Jennison associates4.00M0.06%2.98M
Timessquare capital management895.57K0.34%640.33K
Blackrock funding, inc. /de441.52K0.00%374.85K
Polar capital1.75M0.25%245.00K
Handelsbanken fonder ab187.40K0.02%187.40K

Top Sellers

HolderShares% AssetsChange
Bvf inc/il---1.52M
Fcpm iii services b.v.10.60M45.98%-1.23M
Opaleye management---325.00K
Marshall wace, llp---288.45K
Gmt capital---285.14K

New Positions

HolderShares% AssetsChangeValue
Handelsbanken fonder ab187.40K0.02%187.40K$4.82M
China universal asset management19.59K0.05%19.59K$503.44K
Keybank national association/oh9.98K0.00%9.98K$256.56K
Hb wealth management8.73K0.00%8.73K$224.31K
Mirae asset global investments3.08K0.00%3.08K$79.62K

Sold Out

HolderChange
Global retirement partners-91.00
Assetmark-96.00
Advisor group-142.00
Stone house investment management-325.00
Virtus etf advisers-2.83K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025135-3.57%111,187,22812.82%950.89%78-11.36%336.45%
Dec 31, 202433-67.96%21,547,862-71.71%220.35%19-71.64%8-52.94%
Sep 30, 202410311.96%76,172,3465.78%801.39%6724.07%17-
Jun 30, 20249221.05%72,012,804-0.19%760.99%54-6.90%1754.55%
Mar 31, 202476123.53%72,152,34116.57%871.56%58286.67%11120.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A6.65M6.05%3.57M
Polar Capital Biotech S Inc2.25M2.00%-
Vanguard Health Care Inv2.16M1.96%874.41K
Jennison Health Sciences Equity1.28M1.16%-
Pictet-Biotech P USD970.22K0.86%208.63K
American Funds New Economy A838.90K0.76%838.90K
Capital Group New Economy Comp838.90K0.76%838.90K
PGIM Jennison Health Sciences Z777.28K0.69%-501.37K
Jennison SMid Cap Core Equity715.47K0.65%-
PGIM Jennison Small Company A715.47K0.64%-

Recent Insider Transactions


DateNameRoleActivityValue
May 15, 2025Kling Douglas F Chief Operating OfficerSell$1.84M
Apr 15, 2025Kling Douglas F Chief Operating OfficerSell$1.56M
Apr 15, 2025Kling Douglas F Chief Operating OfficerSell$15.20K
Mar 26, 2025Topper James N-Buy$25.52K
Mar 26, 2025Kling Douglas F Chief Operating OfficerSell-

Insider Transactions Trends


DateBuySell
2025 Q2-3
2025 Q1217
2024 Q4126
2024 Q32-
2024 Q21-

NAMS Ownership FAQ


Who Owns NewAmsterdam Pharma?

NewAmsterdam Pharma shareholders are primarily institutional investors at 95.75%, followed by 0.34% insiders and 3.91% retail investors. The average institutional ownership in NewAmsterdam Pharma's industry, Biotech Stocks , is 63.97%, which NewAmsterdam Pharma exceeds.

Who owns the most shares of NewAmsterdam Pharma?

NewAmsterdam Pharma’s largest shareholders are Fcpm iii services b.v. (10.6M shares, 11.18%), Jennison associates (4M shares, 4.22%), and Medicxi ventures management (jersey) (2.87M shares, 3.03%). Together, they hold 18.43% of NewAmsterdam Pharma’s total shares outstanding.

Does Blackrock own NewAmsterdam Pharma?

BlackRock is not among the top 10 institutional shareholders of NewAmsterdam Pharma.

Who is NewAmsterdam Pharma’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is NewAmsterdam Pharma’s biggest shareholder by percentage of total assets invested, with 45.98% of its assets in 10.6M NewAmsterdam Pharma shares, valued at 272.35M$.

Who is the top mutual fund holder of NewAmsterdam Pharma shares?

American Funds SMALLCAP World A is the top mutual fund holder of NewAmsterdam Pharma shares, with 6.05% of its total shares outstanding invested in 6.65M NewAmsterdam Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools